À PROPOS DE CE PODCAST 🔗

Fréquence de mise à jour:
weekly
Durée audio moyenne:
95 seconds
Anglais
États-Unis
84 épisodes
depuis 17 mars 2026
episodic

DERNIER ÉPISODE 🔗

Dave Mellenberg, medical physicist and advisor to Medsolve Dynamics, on why the people best at the game still work with a team. medsolvedynamics.com · team@medsolvedynamics.com

RECHERCHER LES ÉPISODES PASSÉS

Rechercher les épisodes précédents de Medsolve Dynamics.

ÉPISODES PRÉCÉDENTS

The legal side hasn't caught up with AI, so a program has to ask for the terms itself: an AI addendum to the BAA, and a way to get its data back. From Yoel Bakas's SROA 2026 keynote, From Hype to Value. Medsolve Dynamics is an oncology consulting firm that works with cancer programs on capital, ser…
On November 5 eviCore's new radiation oncology guideline takes effect, and it lists osteoarthritis and plantar fasciitis as not medically necessary. The guideline applies to plans that use eviCore, so the question for a benign program is how much of its volume routes through eviCore.
"I use AI every single day." The opening minute of the SROA 2026 session Yoel Bakas gave with Heather Turner, on the difference between a chatbot a team can switch off and AI built into a multi-year vendor agreement. Yoel Bakas spent thirteen years at Varian, then ran global sales at Mevion, strat…
Two clocks run underneath every capital decision made this fall. One of them can still move. The other one locks. From "Protecting Program Margin, Part Two," AMAC Summer Seminar 2026. Yoel Bakas spent thirteen years at Varian, then ran global sales at Mevion, strategic operations at ViewRay and the…
Acceptance proves the machine is what was bought. It says nothing about the volume the purchase was approved on. Yoel Bakas of Medsolve Dynamics, twenty years on the vendor side of these agreements, on which assumptions a capital purchase puts somebody on the hook for and which ones belong to the p…
Before asking for another treatment machine, establish what limits the ones already in service. Yoel Bakas of Medsolve Dynamics explains why a capital review needs staffed hours and treatment mix beside the activity figures, and how those conditions affect a comparison with the vendor's proposal.  …
Twenty years on the vendor side, and an honest answer about which machine to buy would still have been his machine. Yoel Bakas on where a vendor's physicist sits on that one question, and only that one, and what to write down under each physics arrangement before the next capital decision. Full iss…
One flat service rate on a one-year-old linear accelerator and a twenty-year-old one means the LINAC service contract price is not built from parts, labor, travel or downtime history. Yoel Bakas on the number to check before a radiation oncology service agreement renewal or a service contract negot…
Yoel Bakas on why a competing bid earns its keep even when everyone knows which vendor wins, and what one question did for a vault budget. From Yoel Bakas's AMAC Summer Seminar 2026 session; this cut is an episode of the Medsolve Dynamics podcast. Yoel Bakas ran national accounts at GE HealthCare, …
Avertissement: Le podcast et les illustrations intégrés sur cette page proviennent de Medsolve Dynamics, qui est la propriété de son propriétaire et n'est ni affilié ni approuvé par Listen Notes, Inc.